about
Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infectionTANK-binding kinase-1 plays an important role during in vitro and in vivo type I IFN responses to DNA virus infections.Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.The 22nd annual prostate cancer foundation scientific retreat report.Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting.Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.The 23rd Annual Prostate Cancer Foundation Scientific Retreat report.IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.Global developments in prostate cancer research and clinical practice.Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.IRF3-dependent type I interferon response in B cells regulates CpG-mediated antibody production.The 21st Annual Prostate Cancer Foundation Scientific Retreat report.The 20th Annual Prostate Cancer Foundation Scientific Retreat report.Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group.The 24th Annual Prostate Cancer Foundation scientific retreat reportTumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy MeetingProstate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy MeetingThe 25th Annual Prostate Cancer Foundation Scientific Retreat ReportErratum
P50
Q36402672-F2CE461A-DD42-4904-9BAE-6DAFBB57BE77Q37130854-5EF46062-977E-4E2B-AFBD-5CAF4180010FQ38264014-AA647A71-C696-4387-B739-1CDEC95B7FF5Q38610286-95B40FF6-CED1-4E28-8821-25A4C7CF254DQ38858015-2F71BA5D-D4A6-410C-9B5A-57E21C7A9E92Q38966736-D0BD38AD-357D-4F53-ACA2-2CFAAD9368BBQ38995718-D5CC0D8D-FDFA-4B19-9BF3-C03460C919F4Q39306297-7A34E685-95DF-4868-A5AA-779176353D62Q42139657-483D0458-1912-40F5-9E82-5738627C297CQ42740147-18810452-CED2-4D98-AF36-1382FCA360DFQ43578455-D30EF794-806D-430D-80DD-ABC2F8136580Q46500837-867C5670-8A0A-4DF4-9BF5-6640D7A2721CQ46618887-D28AEE9D-0FEF-4235-8453-260DBD911BD1Q51243945-9E3D3E21-AA8A-4FE8-A594-ADC83733393AQ52803630-C5013C87-925E-4B22-99C0-F0CA28D91ECCQ57107224-C25077E8-551E-452B-B0E8-3B4750549A74Q58091470-3C07DCF2-9233-434E-BB07-767A8AC4968EQ91875640-17712029-D126-4B0D-AD7C-277F06000AEAQ92116163-4D43301D-6783-4FAA-943E-B554BE48AE2FQ95561121-3A1082D7-7A3D-4F44-8FDB-466CB76730D7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea K. Miyahira
@ast
Andrea K. Miyahira
@en
Andrea K. Miyahira
@es
Andrea K. Miyahira
@nl
Andrea K. Miyahira
@sl
type
label
Andrea K. Miyahira
@ast
Andrea K. Miyahira
@en
Andrea K. Miyahira
@es
Andrea K. Miyahira
@nl
Andrea K. Miyahira
@sl
altLabel
Andrea K. Perry
@en
prefLabel
Andrea K. Miyahira
@ast
Andrea K. Miyahira
@en
Andrea K. Miyahira
@es
Andrea K. Miyahira
@nl
Andrea K. Miyahira
@sl
P106
P1153
23397589200
7202159619
P31
P496
0000-0003-4976-002X